Related Experiment Video
Updated: Aug 12, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Homozygous-Recessive Characteristics as a Biomarker of Predisposition for COVID-19
Darko Grujičić1, Ljiljana Mirkov2, Dragić Banković1
1University of Kragujevac, Serbia.
Insights
The homozygous-recessive characteristics (HRC) test may identify individuals predisposed to severe COVID-19. Higher HRC scores correlated with increased COVID-19 risk and disease severity.
Area of Science:
- Genetics
- Epidemiology
- Infectious Diseases
Background:
- Coronavirus disease (COVID-19) emerged as a global pandemic.
- Understanding genetic predispositions is crucial for managing infectious diseases.
Purpose of the Study:
- To analyze homozygous-recessive characteristics (HRC) in COVID-19 patients.
- To investigate the association between HRC and disease severity, risk factors, and demographic factors.
Main Methods:
- A sample of 321 individuals (205 COVID-19 patients, 116 controls) was analyzed.
- Twenty homozygous-recessive characteristics (HRCs) were assessed using the HRC test.
- Statistical analysis was performed to compare HRC between patients and controls, and across different disease severity levels.
Main Results:
- COVID-19 patients exhibited significantly higher average HRC compared to controls.
- Patients with severe COVID-19 symptoms had higher HRC than those with mild symptoms.
- A higher HRC (cut-off ≤5.5) was associated with a 2.3-fold increased risk of COVID-19 (OR = 2.315, p < .0005).
Conclusions:
- The HRC test may serve as a valuable screening tool for identifying COVID-19 predisposition.
- Homozygous-recessive characteristics are linked to increased risk and severity of COVID-19.
Abstract:
Coronavirus disease (COVID-19), a new form of severe acute respiratory syndrome, has caused a global pandemic. The aim of this study was to analyze homozygous-recessive characteristics (HRC) in the group of COVID-19 patients, considering their gender, forms of the disease (mild and severe symptoms), risk factors: hypertension, diabetes mellitus type 2, hyperlipidemia, smoking habits, and the distribution of ABO blood group. Using the HRC test, we analyzed 20 HRCs in a sample of 321 individuals: 205 patients and 116 controls. The average HRC in patients was significantly higher than controls, as well as in patients with severe symptoms compared to patients with mild symptoms. The patients with higher HRC (cut-off ≤5.5) experienced a significantly increased risk of disease of 2.3 times (OR = 2.315, p < .0005). Our results indicate that the HRC test could be used as a screening in recognizing predisposition for COVID-19.
Related Concept Videos
Genetic Lingo
Pedigree Analysis
Single Nucleotide Polymorphisms-SNPs
Multiple Allele Traits
Genetic Variation
Genes exist in different versions called alleles,...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

